Connect with us

Hi, what are you looking for?

Jewish Business News


Carlos Slim in Talks to Invest in Israeli Big Data Analytics Company GSTAT

Big data analytics company GSTAT confirms that Carlos Slim is considering investing tens of millions of shekels in it.

Carlos Slim / Getty

Carlos Slim is in talks to invest in big data analytics developer GSTAT Software Solutions Ltd., following his investment in Mobli Ltd.

GSTAT today confirmed reports that Slim was considering investing tens of millions of shekels in the company soon. GSTAT VP sales and business development Ori Davidovich represented the company was part of President Shimon Peres’s entourage during his visit to Mexico last week, and met with Carlos Slim and his son.

GSTAT was founded in 2001 by president Ephraim Goldin. It initially provided business intelligence (BI) solutions to Israeli telcos and financial companies. Three years ago, it launched a big data analytics product to break into the global BI market. Although the BI market is crowded, soaring demand for statistical analysis for marketing gave the company an opening.

Gstat established contact with Slim as part of the company’s effort to enter the Latin American market, and a multimillion-dollar contract with mobile carrier Claro, a unit of Slim’s of América Móvil SAB de CV (BMV; NYSE: AMX; Nasdaq: AMOV; BMAD: AMXL).

In the past couple of years, GSTAT has been seeking an investor to help it sell its product, and Slim could be a good solution. GSTAT will use the investment, if made, to fund its strategy to expand its solutions to Latin American telcos and financial companies.

Published by

1 Comment

1 Comment

  1. Pingback: 10,004 additional investors in Israel

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


Now Platika joins and elite club of $10 billion plus Israeli firms.